Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-048905

SVP, Chief Accounting Officer sold 2,163 shares at an average $40.80 ($88,249)

  • SVP, Chief Accounting Officer acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Huizenga Theodore Alan · SVP, Chief Accounting Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-07 Exercise or conversion : show line 1 in the form +2,000 $21.00 $42,000 25,777 D
2023-09-07 Sale : show line 2 in the form −2,000 $41.00 $82,000 23,777 D
2023-09-07 Sale : show line 3 in the form −163 $38.34 $6,249 23,614 D
Open-market sales · 2,163 sh · avg $40.80 · $88,249

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-07 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −2,000 3,000 D
Loading xslF345X05/doc4.xml…